Back to Search
Start Over
1206P HER2 copy number variation (CNV), HER2 expression and primary resistance mechanisms in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction cancer (mGC/GEJC) receiving first-line chemotherapy (CT) + trastuzumab (T) +/- pertuzumab (P) in the JACOB trial
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS1100-S1101. 2p. - Publication Year :
- 2022
- Subjects :
- *ESOPHAGOGASTRIC junction
*TRASTUZUMAB
*CANCER chemotherapy
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159078108
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1324